Exodus Point Capital Management, LP I Bio, Inc. Transaction History

Exodus Point Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$0.55 - $1.04 $20,062 - $37,936	-36,477 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.06 - $1.52 $2,245 - $3,219	-2,118 Reduced 5.49%	36,477 $39,000
Q2 2021 Aug 16, 2021	BUY	$1.22 - $1.65 $47,085 - $63,681	38,595 New	38,595 $58,000
Q2 2020 Aug 14, 2020	SELL	$0.87 - $2.46 $34,452 - $97,416	-39,600 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$0.22 - $2.45 $6,305 - $70,221	28,662 Added 262.04%	39,600 $42,000
Q4 2019 Feb 14, 2020	BUY	$0.11 - $0.58 $1,203 - $6,344	10,938 New	10,938 $3,000

Ticker IBIO
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,006,580
Market Cap $24M
Description
iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.